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Abstract: Breast conserving surgery has become the standard of care and is more commonly per-
formed than mastectomy for early stage breast cancer, with recent studies showing equivalent
survival and lower morbidity. Accurate preoperative lesion localization is mandatory to obtain
adequate oncological and cosmetic results. Image guidance assures the precision requested for this
purpose. This review provides a summary of all techniques currently available, ranging from the
classic wire positioning to the newer magnetic seed localization. We describe the procedures and
equipment necessary for each method, outlining the advantages and disadvantages, with a focus
on the cost-effective preoperative skin tattoo technique performed at our centre. Breast surgeons
and radiologists have to consider ongoing technological developments in order to assess the best
localization method for each individual patient and clinical setting.
Keywords: breast cancer; breast-conserving surgery; non-palpable breast lesions; image-guided
localization; preoperative breast localization; breast ultrasound
1. Introduction
Breast cancer (BC) is the most commonly diagnosed cancer and the leading cause
of cancer-related death among women [1]. A successful BC treatment is based on a
multidisciplinary use of surgery, chemotherapy and radiation therapy, with surgery as
the central component of treatment for early-stage breast cancer [2,3]. Breast-conserving
surgery (BCS) followed by adjuvant radiotherapy, known as breast conservation therapy
(BCT), has become the alternative treatment to mastectomy for early stage breast cancer
because of equivalent survival and lower morbidity [4–6].
Local recurrence after BCS is strongly correlated to the surgical margin status, as
demonstrated by a large number of follow-up studies [7–11]. The main goal of BCS is
to fully remove the tumor with clear margins, while avoiding resection of healthy breast
tissue in order to achieve better cosmetic results. Image-guided preoperative localization is
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mandatory for guiding surgery of non-palpable lesions or surgically relevant extension
of palpable lesions to improve both oncological and cosmetic outcomes [12,13]. Over the
last decade, methods for preoperative localization of breast lesions for BCS have evolved
rapidly due to innovative techniques and discovery of novel agents. However, cooperation
and communication between breast surgeons and radiologists still play a crucial role.
Different image guided localization techniques are variably used in different insti-
tutions depending on personal choices, skills and available technologies. As a general
rule, the method chosen should be the most precise to localize the lesion or marker left
after biopsy, thus improving free margin rates and decreasing operative time, and pos-
sibly cause little to no discomfort to the patient. Preoperative breast lesions localization
techniques currently available are wire localization, carbon marking, radio-guided occult
lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization
and non-radioactive radar localization, intraoperative ultrasound and preoperative skin
tattoo localization (Table 1). In this article, we provide an overview of current literature
of all commercially available techniques. The aim of this review is to educate practicing
radiologists and breast surgeons so they can knowingly select new techniques to improve
patient care.
Table 1. Comparison of different localization techniques. Abbreviations: ROLL = radio-guided occult lesion localization;
RSL = radioactive seed localization; Magseed = magnetic seed localization; IOUS = intraoperative ultrasound; Skin tattoo
= preoperative localization with skin tattoo; OR = operating room; US = ultrasound; MRI = magnetic resonance imaging.
* Success is defined as removal of target lesion. ** Authors’ experience.
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2. Wire Guided Localization
Wire localization (WL) was introduced in the 1970s and for many years has served as
the only method for preoperative breast localization [36]. Initially, mammography was the
only imaging modality used to guide wire placement. Currently, wire localization can be
performed under different kinds of image-guidance (mammographic, sonographic and
magnetic resonance imaging). WL is the most commonly used method for non-palpable
breast lesions, with clear margins reported in a range of 70.8%–87.4% of cases [15]. Different
types of wires are available, ranging in length (from 3 to 15 cm), shape (hook, barb or
pigtail), materials and numbers of thickened segments [12,13,15,36,37]. Wires are preloaded
in a 16–21 G needle introducer: when the tip is just beyond the target, the hook is deployed
by fixing the needle firmly with one hand and gently advancing the wire with the other. The
needle is then removed over the wire and the thread extending from the tip of the hookwire
is secured on the skin surface. Routinely, post-procedural CC and ML mammograms
were obtained to confirm accurate placement (Figure 1). The depth of the wire tip from
the skin surface is also recorded. In case of extensive disease wires can be placed in
multiple numbers, allowing targeted localization in a procedure known as “bracketing wire
localization” [38]. WL remains the most widely adopted approach due to the long-term data
supporting its effectiveness [39], although success is strongly dependent upon the surgeon’s
mental reconstruction of the images, perceived intraoperative position of the lesion and
wire trajectory [40]. Approximately 2.5% of wire localizations are unsuccessful; factors
associated with an increased risk of unsuccessful localization are multiple lesions, small
lesions, lesions containing extensive microcalcifications and small surgical specimens [14].
Established advantages of WL are the widespread availability and the moderate price, with
one study estimating the cost of a needle at $22.50 [41].
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Figure 1. Wire-guided localization. Craniocaudal (a) and mediolateral (b) oblique mammograms taken after hookwires 
insertion show optimal wires positioning, with the wires at the biopsy markers site. A specimen radiograph (c) contains 
the hookwire and the residual calcifications (circle). 
. ire- i l li
i s o optimal wires positioning, with the wires at the biopsy markers site. A specimen radiograph (c) contai s the
hookwire and the residual calcifications (circle).
Moreover, wires emit no ionizing radiation and can be stored safely within the imaging
department. This approach also allows localizations of breast lesions under different kinds
of image guidance (US, mammography/tomosynthesis or MRI). Although WL is highly
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effective, it still yields several disadvantages. The procedure is in itself unpleasant and
causes patient discomfort; vasovagal reactions are reported in up to 7–10% of patients,
although less frequent for US than for mammography guided procedures [12]. Wire
migration within the breast, and more infrequently outside the breast, has also been
reported [42,43]. The hookwire can be transected during the surgery, with pieces being
retained in the breast post-operatively [44,45]. Finally, this localization approach requires
adequate coordination between trained breast radiologists and surgeons because the wire
placement has to occur on the day of surgery to avoid displacement. This limitation
can lead to inconvenience and delay in the operating room or suboptimal localization.
Moreover, wire localization could limit the surgical approach and cause a potential worse
cosmetic outcome; the placement route of the wire, chosen by the radiologist, often dictates
incision choice for the surgeon who then has to follow the wire’s course during dissection.
3. Carbon Marking
Carbon marking (CM) is an alternative method for non-palpable breast lesion localiza-
tion first reported by Svane in 1983, consisting of an injection of sterile charcoal powder
diluted with saline solution in close proximity to the lesion [46]. The injection can be
performed under either sonographic or mammographic guidance, depending on how the
target lesion has been biopsied [17]. A dark trail is created from the lesion to the skin,
leaving a visible track that guides the surgeon during the operation. As the carbon track is
immobile in breast tissue, it cannot dislodge. In contrast, hookwires can migrate when the
patient changes position or when traction is applied during surgery. The main advantages
of CM are logistics, patient comfort and cost. As CM and biopsies could be concurrent, the
patient may be spared an extra invasive procedure. Moreover, surgery may be planned
up to 1 month after the carbon injection, making operative planning easier for surgeons
and sparing radiologists the pressure to place hookwires immediately before or during
an operating session. The success rate using carbon marking is very high, with failure to
remove targeted lesion occurring in about 1 in every 100 procedures [16]. However, there
are cases in which CM presents technical difficulties. If the lesion is close to the chest wall,
particularly in a large breast, or for extensive or multifocal lesions, long and several carbon
tracks will be difficult for the surgeon to follow and a hookwire may be preferable. For
extensive or multifocal lesions several carbon tracks are difficult to follow, and WL may be
preferable [46]. The disadvantages are that the carbon tracks resist slicing, thus the carbon
can distort or obscure the lesion. To avoid this, the carbon should be injected only as far
as the edge of the lesion. Another possible, although uncommon, complication of CM
is the incomplete surgical removal of the injected charcoal, which can cause a late-onset
granuloma that may mimic malignant lesions in postoperative controls [47,48]. In terms of
missed lesions and clear margin rates, CL shows similar results as WG: the proportion of
cases with close or involved margins ranges between 15% (for invasive cancer) and 39% (in
situonly lesions) [17,18].
4. Radio-Guided Occult Lesion Localization
Radio-guided occult lesion localization (ROLL) involves intratumoral injection of a
small amount (0.2–0.3 mL) of human serum albumin marked with nuclear radiotracer
technetium 99 [49] (Figure 2). This localization technique can be performed either by
ultrasonography, stereotactic mammography or MRI.




Figure 2. Radio-guided occult lesion localization (ROLL) technique: (a) invasive ductal cancer (arrow) in the left upper 
outer quadrant in a 77-year-old woman. (b) Intratumoral injection (arrow head) of a small amount (0.2–0.3 mL) of human 
serum albumin marked with nuclear radiotracer technetium 99 in order to perform radio-guided occult lesion localization. 
The radiation dose is of about 7–10 MBq, equivalent to 1–2% of the dose used for a 
whole-body bone scintigraphy [50]. A handheld gamma ray detection probe is used by 
the surgeon to locate the lesion, guide the removal and verify the removed specimen and 
the surgical bed. To allow an adequate detection, surgery has to be performed no later 
than 24 h after the injection of the radiotracer. ROLL has gained popularity on account of 
several advantages associated with a reduced excision volume, more accurate centricity 
of a lesion within the surgical specimen, better cosmetic results and a higher percentage 
of tumor-free margins, around 92% of cases [20,21]. There are no serious complications 
related to ROLL, even though experience in the injection is needed to avoid failure of le-
sion identification, described only in 1–5% of the cases [19]. ROLL can be performed to-
gether with sentinel lymph node identification in the same surgical session, in a procedure 
known as sentinel node and occult lesion localization (SNOLL), that involves the injection 
of an additional radiotracer (carried by micromolecules instead of macromolecules used 
for ROLL) [51,52].  
5. Radioactive Seed Localization 
Radioactive seed localization (RSL) using Iodine-125 seeds has been proposed in 1999 
by Dauway as an attractive alternative to both WL and ROLL. This technique involves 
targeted placement of a seed, commonly used for brachytherapy, composed of titanium 
labeled 0.075–0.3 mCi of Iodine-125. Each seed has a half-life (T 1/2) of 59 days and a ra-
dioactivity of about 20–30 MBq, a dose equivalent to 3–5% of that used for a whole-body 
bone scintigraphy [53]. Radioactive seeds can be positioned under different image guid-
ance, ultrasonography, mammography/tomosynthesis or MRI. An 18G needle preloaded 
or manually loaded with the seed was used, and the tip was occluded by bone wax. Once 
the needle advanced to the desired location, the seed was deployed through the bone wax 
by advancing the stilette. At the end of the procedure, regardless of the guidance method, 
the patient was assessed for radioactivity with a Geiger counter and post-procedural 
mammograms with two orthogonal images reconfirm proper seed positioning [54]. Dur-
ing surgery a gamma probe set for I-125 guides the surgeon. The different energy peak of 
technentium-99 and iodine-125 allows one to differentiate the isotope used for sentinel 
node biopsy. Radioactive seed localization could potentially be performed weeks before 
the scheduled surgery because of the long half-life (59 days) of I 125; however, according 
to Nuclear Regulatory Commission guidelines the procedure should be carried out no 
more than 7 days before surgery in order to minimize radiation exposure [55]. In fact, one 
of the potential drawbacks of RSL is the presence of radioactivity. Although the activity 
levels of the seeds are low and considered safe for human exposure, patients are advised 
to avoid interactions with children and pregnant women to mitigate any potential risk. 
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even though experience in the injection is needed to avoid failure of lesion identification,
described only in 1–5% of the cases [19]. ROLL can be performed together with sentinel
lymph node identification in the same surgical session, in a procedure known as sentinel
node and occult lesion localization (SNOLL), that involves the injection of an additional
radiotracer (carried by micromolecules instead of macromolecules used for ROLL) [51,52].
5. Radioactive Seed Localization
Radioactive seed localization (RSL) using Iodine-125 seeds has been proposed in 1999
by Dauway as an attractive alternative to both WL and ROLL. This technique involves
targeted placement of a seed, commonly used for brachytherapy, composed of titanium
labeled 0.075–0.3 mCi of Iodine-125. Each seed has a half-life (T 1/2) of 59 days and a
radioactivity of about 20–30 MBq, a dose equivalent to 3–5% of that used for a whole-body
bone scintigraphy [53]. Radioactive seeds can be positioned under different image guidance,
ultrasonography, mammography/tomosynthesis or MRI. An 18G needle preloaded or
manually loaded with the seed was used, and the tip was occluded by bone wax. Once
the needle advanced to the desired location, the seed was deployed through the bone wax
by advancing the stilette. At the end of the procedure, regardless of the guidance method,
the patient was assessed for radioactivity with a Geiger counter and post-procedural
mammograms with two orthogonal images reconfirm proper seed positioning [54]. During
surgery a gamma probe set for I-125 guides the surgeon. The different energy peak of
technentiu -99 and iodine-125 allows one to differentiate the isotope used for sentinel
node biopsy. Radioactive seed localization could potentially be performed weeks before
the scheduled surgery because of the long half-life (59 days) of I 125; however, according to
Nuclear Regulatory Commission guidelines the procedure should be carried out no more
than 7 days before surgery in order to minimize radiation exposure [55]. In fact, one of the
potential drawbacks of RSL is the presence of radioactivity. Although the activity levels of
the seeds are low and consid red safe for human exposure, patients are advised to av id
interactions with children and pregnant wom to mitigate any potential risk. Moreover,
a strict local protocol f r quality a surance must be followed in order to guarantee that
all implanted seeds are actua ly removed and recovered by the local Nuclear Medicine
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Department. An undeniable benefit of both ROLL and RSL is that the surgeon is no longer
impeded by the guidewire when planning breast incision and can use the feedback from
the gamma probe to reorientate the surgical approach in real time.
Given oncoplastic breast techniques, this allows greater choice of cosmetically sensitive
approaches, such as periareolar, lateral or inframammary fold incisions [56]. Current
literature comparing RSL and WL margin status achievements shows variable results, with
some studies favoring RSL and more recent studies, including three randomized control
trials, suggesting no difference between the two methods [40,57,58]. Due to the real-time
intraoperative monitoring of the detected gamma counts from the seed, RSL allows an
accurate lesion localization with lower incidence of positive margins and decreased need
for repeat surgery than with wire localization. The success rate using RSL is very high:
target lesion is effectively removed in nearly 100% of cases and clear margin rates range
from 73.5% to 96.7% [22,23].
6. Magnetic Seed Localization
Magnetic seed is a novel localization technique approved by the FDA in 2016 [24].
This technique shares many similarities with RSL, because it consists in seed placement
under sonographic or tomosynthesis guidance, however it does not involve radioactivity.
First introduced by Sentimag (Magseed®, London, UK), magnetic seeds are cylindrical
markers, measuring approximately 5 mm × 1 mm, made of paramagnetic steel and iron
oxide. They can be deployed by an 18 G preloaded needle of different length according to
different breast sizes (Figure 3). Following insertion, mammograms in double projection
are acquired to confirm correct positioning of the seed. The Sentimag probe employed in
the operating room generates an alternating magnetic field that temporarily magnetizes the
Magseed, and subsequently measures its magnetic field. The surgical technique is therefore
similar to that adopted after ROLL or RSL, involving a live numerical feedback that guides
surgical direction and reveals the remaining distance from lesion. A final assessment
is conducted by probing the specimen and the surgical cavity, and potentially verified
with specimen X-ray confirming excision of seed. While sharing with ROLL and RSL the
important benefit of granting maximum liberty in the choice of incision, this technique has
the further benefit of avoiding exposure to radiation. It also eases coordination between
Radiology and Surgery Departments, because seed placement, initially approved for up
to 30 days prior to surgery, has now been extended in Europe and USA for long-term
implantation [25]. However, while this seed could be potentially implantable during
biopsies and even before neoadjuvant treatment, one major drawback is that it interferes
with MR imaging by creating artifacts as wide as 4 cm [12]. Another challenge with this
technique is that during surgery all ferromagnetic instruments will interfere with the
signal. A dedicated set of non-ferromagnetic surgical instruments is therefore always
necessary, and weighs on cost-effectiveness [13]. Studies on the efficacy of this technique in
terms of successful excision, clear margins and optimal volume of resection are few and
include relatively small populations of patients, however preliminary data is encouraging,
with a successful placement rate of 94.42%, a successful localization rate of 99.86% and a
percentage of clear margins of 88.75% [24,26,27,59].




Figure 3. Magseed positioning in a 49-year-old woman with ductal carcinoma in situ. Ultrasound images of the right upper 
outer quadrant. Biopsy marker is visible in the lesion (a, arrow). Magseed magnetic marker is placed under ultrasound 
guidance (b, arrow shows the needle). Magseed®  marker is clearly seen in the lesion (c, arrow). 
7. Radiofrequency Identification Tags 
Radio frequency reflector (RFR) is a non-ionizing electromagnetic wave tagging de-
vice for localizing non-palpable breast lesions approved in the United States by FDA in 
2014 [28]. The identification tag, as any biopsy clip marker, can be placed by radiologists 
under mammographic, tomosynthesis or ultrasound guidance. The injection can take 
place up to 30 days preoperatively. During surgery, the surgeon activates the reflector 
with the hand piece and follows the signal to guide the excision. The audible and numer-
ical signals change with increasing proximity to the lesion. Once the tissue is removed, 
the reader console can be used to confirm that all tags have been removed from the tissue 
cavity. RFRs differ in size and shape from vendor to vendor. One of the first available RFR 
is SAVI SCOUT (Cianna Medical, Aliso Viejo, CA, USA) and another more recent device 
is the LOCalizer (Faxitron, Tucson, AZ, USA). The SAVI SCOUT reflector has been rated 
as MR conditional and be considered safe to image in a static magnetic field of 3 Tesla or 
less and a maximum spatial gradient magnetic field of 3000 G or less [29]. Whereas metal-
lic interference from nearby surgical instruments can interfere with detection of magnetic 
seeds, metal does not interfere with detection of radiofrequency signals during surgery 
[59]. Radiofrequency identification tag is an effective technique: data from the literature 
report success rates of 97–100% and clear margin rates ranging between 85% and 100% 
[30,31]. The main advantage of RFR localization over wire localization is the decoupling 
of the radiology and surgery schedules; moreover, it avoids the risk of complications as-
sociated with an external wire component. Compared to RSL, RFR is a non-ionizing sys-
tem and does not require extensive multidisciplinary coordination or regulatory compli-
ance. Disadvantages of localization with the SAVI SCOUT device include its relatively 
large size (12 mm), especially for small subcentimetric lesions. The LOCalizer overcomes 
the size hurdle since it is smaller. Other limitations include the inability to reposition the 
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7. Radiofrequency Identification Tags
Radio frequency reflector (RFR) is a non-ionizing electromagnetic wave tagging device
for localizing non-palpable breast lesions approved in the United States by FDA in 2014 [28].
The identification tag, as any biopsy clip marker, can be placed by radiologists under
mammographic, tomosynthesis or ultrasound guidance. The injection can take place up to
30 days preoperatively. During surgery, the surgeon activates the reflector with the hand
piece and follows the signal to guide the excision. The audible and numerical signals change
with increasing proximity to the lesion. Once the tissue is removed, the reader console
can be used to confirm that all tags have been removed from the tissue cavity. RFRs differ
in size and shape from vendor to vendor. One of the first available RFR is SAVI SCOUT
(Cianna Medical, Aliso Viejo, CA, USA) and another more recent device is the LOCalizer
(Faxitron, Tucson, AZ, USA). The SAVI SCOUT reflector has been rated as MR conditional
and be considered safe to image in a static magnetic field of 3 Tesla or less and a maximum
spatial gradient magnetic field of 3000 G or less [29]. Whereas metallic interference from
nearby surgical instruments can interfere with detection of magnetic seeds, metal does not
interfere with detection of radiofrequency signals during surgery [59]. Radiofrequency
identification tag is an effective technique: data from the literature report success rates
of 97–100% and clear margin rates ranging between 85% and 100% [30,31]. The main
advantage of RFR localization over wire localization is the decoupling of the radiology
and surgery schedules; moreover, it avoids the risk of c mplications associated with an
external ire component. Compared to RSL, RFR is a n n-ionizing system and does not
r quire exten ive multidiscipli ary coordination or regulatory compliance. Disadvantages
of local z tion with the SAVI SCOUT device include its relatively large size (12 mm),
especially for s all ubcentimetric lesions. The LOCalizer overcomes th size hurdle
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since it is smaller. Other limitations include the inability to reposition the reflector once
deployed and the maximum lesion detection depth, as studies have reported problems in
intraoperative detection of the reflector in women with large breasts and lesions located
>6 cm from the overlying skin surface [30].
8. Intraoperative Ultrasound
Intraoperative ultrasound (IOUS) was first described by Schwartz et al. in 1988
and has gradually spread and evolved with other techniques due to growing experience
and technological advances. A sterile-gowned ultrasound probe has to be available in
the operating room. The procedure begins at the operating table before incision, once
painting and draping procedures have been carried out. The surgeon locates the tumor
by ultrasonography and measures its diameter and distance from surrounding hallmarks,
such as skin surface, nipple–areolar complex (NAC) and fascia. The surgical approach is
then planned in full liberty, and after incision the dissection is carried out by repeatedly
reassessing the tumor’s position and the distance between the surgical plane and its
margins. Once the excision has been completed, specimen ultrasound is performed at
the operating table to assess margins, and additional shaving excisions can be acquired if
necessary. This technique is highly effective, with identification rates close to 100% [31–35],
and studies focusing on margin status have shown that IOUS guided surgeries yield less
positive resection margins compared to WGL [32], with free-margin percentages ranging
from 81% to 97% [33–35]. Free margin rates are enhanced by IOUS even in resection of
palpable lesions [60]. A study by James et al. has instead shown no significant differences
in margin status between IOUS and mammographic WGL in patients undergoing surgery
for carcinoma in situ, although the authors still recommend performing IOUS as it is more
cost-effective [61]. Compared to other techniques, IOUS yields several practical advantages:
it does not increase patient presurgery psychological stress, as it is non-invasive compared
to techniques involving breast compression or puncture; it grants full liberty to the surgeon
in choosing the most convenient oncoplastic surgical approach; it does not aggravate
organizational problems and coordination between several departments, as it takes place
directly in the operating room and can be carried out completely by the surgeon himself [62].
To this regard, the learning curve of specialists not necessarily familiar with manipulating
ultrasounds, such as surgeons, could potentially pose an issue, however a study by Krekel
et al. suggests that performance of eight procedures is enough for the surgeon to acquire the
expertise necessary to combine ultrasounds to palpation-guided surgery [63]. Drawbacks
include technical problems resulting from combining ultrasound with surgery, such as
air infiltration beneath the probe that can impede visualization, and refraction issues that
can arise when scanning tissue that is irregular in shape [32]. The major, insurmountable
issue of this technique is however represented by its inability to localize sonographically
invisible tumors. To overcome this problem, some authors have described this technique in
combination with hematoma-guided surgery after MRI- or stereotactically-guided biopsies,
with mixed results [64].
9. Preoperative Localization with a Skin Tattoo
Preoperative localization with a skin tattoo is a simple and safe technique amply
utilized in our centre, as it is easily performed, extremely well tolerated by patients and
effective in terms of successful excision and clear margin rates. This method can be carried
out by acquiring either sonographic or mammographic images, depending on the type of
lesion, but ultrasounds are employed whenever possible because the procedure is easier.
In this case, patients lie in the supine position with their arms extended to mimic the
position held during surgery. The tumor is located, and its distance from the skin surface is
measured taking care not to apply pressure with the probe, so as to report accurately the
depth of the tumor in relation to the skin surface [65]. The distance between the lesion, the
nipple and the pectoralis major muscle is also measured, as is the distance between separate
lesions in case of multifocal or multicentric disease [44,66]. Radiologists with experience
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in this technique visualize the tumors at their largest diameter to achieve the optimal
correspondence between the lesion and the skin markers. The tumor’s projection on the
skin surface is pinpointed with a dermographic skin marker and the drawing is covered to
avoid accidental erasure (Figure 4). The whole procedure, performed by an experienced
radiologist, takes 5–10 min and provides minimum patient discomfort. Limitations include
poor results in case of sonographically invisible lesions, microcalcifications or biopsy
markers, but are easily overcome by implementing this technique with a mammographic
approach. Stereotactic-guided skin marking is also a non-invasive technique, albeit it
provides a little more discomfort to the patient due to breast compression. Mammograms
are acquired in double projection and measurements are performed on the images to
determine the distance between the lesion and the nipple, the skin surface and the fascia.
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measured (c). The dermographic skin markers of the tumor’s projection on the skin surface (d).
The radiologist then esti ates the projection of the tu or on the skin surface and
positions a lead marker in the corresponding spot. In case of bigger lesions, such as
extensive microcalcifications, or multifocal disease, multiple lead markers can be employed
to determine lesion margins. A second stereotactic pair of images is acquired to confirm
the corre t localization, and in case of inaccurate positioning, the lead markers can be
repositioned more accurately and confirmed by a further mammogram [67] (Figure 5).
At the end of the p ocedure the lead markers are removed, and the skin tattoo is drawn
in their place. In the operating room, the mark is expos d nd retraced with a specific
marker resistant to antiseptic olutions, a d painting a d draping proc du es are carried
out carefully thout wiping out the ink. Ou centre str ngly advocates pursuit of the
maximum aes hetic resu t achievable with oncological safety, and because th s localization
technique employs only a temporary skin tattoo, the su geon is granted total liberty in
choice of incision and oncoplastic technique. The skin flap is dissected in the direc ion
of the tattoo, then th incision is deepen d and a lump ct my is carried out taking into
account tumor depth measured during the preoperative localizatio . In some cases, a
non-palpable lesion becomes palpable after dissection of the skin flap, allowing the surgeon
to easily complete the excisi n, however in most cases the excision has to be conducted by
reassessing the original position of the skin mark from time to time. Once the excision is
completed, metallic clips are placed on the orienting sutures in different numbers, so as
to recognize margins in the specimen X-ray. The sample is then placed into a transparent
plastic bag and sent to the Radiology Depart ent, and mammograms are acquired in
double projection. The tumor is usually visible as a radiopaque nodule, and its position
inside the lumpectomy specimen is described as either well centered or close to one or more
surgical margins, and reported to the operating surgeon. In dense, glandular specimens
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the nodule can be difficult to distinguish from the surrounding mammary parenchyma:
in these cases, the exam can be completed with a specimen ultrasound [68] (Figure 6). If
close margins are detected in either technique the surgeon can acquire further cavity shave
margins on the affected border.
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department, and is therefore feasible even with scarce resources. Limitations include
accurate scheduling to time the procedure before surgery thus avoiding accidental mark
erasure, and a certain degree of experience by the surgeon in reassessing the tumor’s
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position based on the skin mark during dissection. Reports on this technique are widely
deficient in the literature, however a preliminary analysis of the data from our high-
volume centre examining the outcome of 199 lumpectomies performed for non-palpable
breast tumors between August and December 2019 identified a global success rate of
99.5% (198/199) and a clear margins rate of 95.9% (192/199). As these rates did not differ
significantly from other localization techniques, this method appears safe and especially
ideal in the case of limited resources or spending reviews.
10. Conclusions
Image-guided preoperative localization of breast lesions is a common procedure that
has rapidly evolved throughout the last decades. Continuous technological developments
and results from new clinical trials have provided growing insight and new possibilities for
breast specialists to select upon various effective techniques. However, to date, no single
perfect method exists. Therefore, the optimal approach should be tailored on each patient
by taking into account preoperative disease characterization (both radiologic and histologic)
and consulting all stakeholders, including surgeons, radiologists and pathologists.
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